$MNKD Can history repeat itself ? Afrezza was FDA approved in June 2014 and the night before Mannkind 2Q 2014 earnings release and call scheduled for August 11, 2014, they issued a press release announcing Sanofi Global Partnership Deal. Tyvaso DPI was FDA approved in May 2022 and how about Mannkind delivering another major partnership deal possibly with United just prior to Mannkind 2Q 2022 earnings release anc call to be scheduled the week of August 8th.
2
2
2 Likes